Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00581295 · ClinicalTrials.gov registry record
Use of Diffuse Optical Spectroscopy for Evaluation of the Trauma/Critically Care Patients
A clinical trial, sponsored by University of California, Irvine.
- Completed
- Registry status
- 93
- Enrollment target
NCT00581295 is a clinical trial that has completed, run by University of California, Irvine. The registered enrollment target is 93 participants.
The verdict
NCT00581295 has completed, sponsored by University of California, Irvine.
- COMPLETED
- Registry status
- 93 participants
- Enrollment target
Study Summary
Trauma remains the leading cause of death and disability for Americans age 1-44. Trauma can cause internal bleeding, and this bleeding is often hard to detect without sophisticate tests that take time to complete and analyze. In addition, internal bleeding, including bleeding into the lung and chest cavity, as well as other blood loss, happens in many critically ill patients. For example, for hemorrhage, it is very difficult to detect active hemorrhage and to determine optimal rates of fluid and blood resuscitation. Diffuse optical spectroscopy has the potential to accurately assess adequacy of tissue perfusion, oxygenation, tissue oxygen extraction, and cytochrome oxidation states that may be critical to optimal treatment, end- organ preservation, and survival.
Interventions
- DEVICE Diffuse optical spectroscopy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 93 participants |
| Start Date | 2007-03 |
| Est. Completion | 2011-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00581295
The ClinicalTrials.gov registry entry for NCT00581295 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 93 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Irvine, which has 368 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Diffuse optical spectroscopy is the first listed.
NCT00581295 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00581295 about?
NCT00581295 is a clinical study titled "Use of Diffuse Optical Spectroscopy for Evaluation of the Trauma/Critically Care Patients". Trauma remains the leading cause of death and disability for Americans age 1-44. Trauma can cause internal bleeding, and this bleeding is often hard to detect without sophisticate tests that take time to complete and analyze. In addition, internal bleeding, including bleeding into the lung and ches...
What is the current status of trial NCT00581295?
This trial is currently completed. The enrollment target is 93 participants. The study started on 2007-03. Estimated completion is 2011-04.
What interventions are being tested in trial NCT00581295?
The interventions under investigation include: Diffuse optical spectroscopy (DEVICE).
Who is sponsoring clinical trial NCT00581295?
This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.